Search research articles
Contact Us
Filters
Showing results (51-60 of 67) with videos related to
Page
of 7
Sort By:
Diagnostic and Interventional Imaging
|
February 22, 2023
Imaging presentation of extraskeletal osteosarcomas on CT and MRI and correlation with patients outcome: A two-center retrospective study of 54 patients
Amandine Crombé, Paolo Spinnato, Alberto Righi, et al.
Molecular Cancer
|
February 19, 2024
Impact of metronomic trabectedin combined with low-dose cyclophosphamide on sarcoma microenvironment and correlation with clinical outcome: results from the TARMIC study
Cheng-Ming Sun, Maud Toulmonde, Mariella Spalato-Ceruso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 26, 2021
Regorafenib-Avelumab Combination in Patients with Microsatellite Stable Colorectal Cancer (REGOMUNE): A Single-arm, Open-label, Phase II Trial
Sophie Cousin, Coralie Cantarel, Jean-Philippe Guegan, et al.
AJR. American Journal of Roentgenology
|
September 29, 2020
Progressive Desmoid Tumor: Radiomics Compared With Conventional Response Criteria for Predicting Progression During Systemic Therapy-A Multicenter Study by the French Sarcoma Group
Amandine Crombé, Michèle Kind, Isabelle Ray-Coquard, et al.
Annals of Surgical Oncology
|
September 30, 2023
Initial Active Surveillance Strategy for Patients with Peripheral Sporadic Primary Desmoid-Type Fibromatosis: A Multicentric Phase II Observational Trial
Sylvie Bonvalot, Nathalie Cozic, Axel Le Cesne, et al.
Nature Cancer
|
April 9, 2025
Regorafenib plus avelumab in advanced gastroenteropancreatic neuroendocrine neoplasms: a phase 2 trial and correlative analysis
Sophie Cousin, Jean-Philippe Guégan, Lola Jade Palmieri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 30, 2021
Trabectedin plus Durvalumab in Patients with Advanced Pretreated Soft Tissue Sarcoma and Ovarian Carcinoma (TRAMUNE): An Open-Label, Multicenter Phase Ib Study
Maud Toulmonde, Mehdi Brahmi, Antoine Giraud, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 8, 2022
Regorafenib-avelumab combination in patients with biliary tract cancer (REGOMUNE): a single-arm, open-label, phase II trial
Sophie Cousin, Coralie Cantarel, Jean-Philippe Guegan, et al.
Cancers
|
January 10, 2026
The Role of Computed Tomography-Determined Total Tumor Volume at Baseline in Predicting Outcomes of Patients with Locally Advanced Unresectable or Metastatic Pancreatic Ductal Adenocarcinoma
Elissar Moujaes, Jules Dupont, Littisha Lawrance, et al.
Investigative Radiology
|
October 26, 2012
Standardization of dynamic contrast-enhanced ultrasound for the evaluation of antiangiogenic therapies: the French multicenter Support for Innovative and Expensive Techniques Study
Nathalie Lassau, Louis Chapotot, Baya Benatsou, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 67) with videos related to
Sort By:
Page
of 7
Diagnostic and Interventional Imaging
|
February 22, 2023
Imaging presentation of extraskeletal osteosarcomas on CT and MRI and correlation with patients outcome: A two-center retrospective study of 54 patients
Amandine Crombé, Paolo Spinnato, Alberto Righi, et al.
Molecular Cancer
|
February 19, 2024
Impact of metronomic trabectedin combined with low-dose cyclophosphamide on sarcoma microenvironment and correlation with clinical outcome: results from the TARMIC study
Cheng-Ming Sun, Maud Toulmonde, Mariella Spalato-Ceruso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 26, 2021
Regorafenib-Avelumab Combination in Patients with Microsatellite Stable Colorectal Cancer (REGOMUNE): A Single-arm, Open-label, Phase II Trial
Sophie Cousin, Coralie Cantarel, Jean-Philippe Guegan, et al.
AJR. American Journal of Roentgenology
|
September 29, 2020
Progressive Desmoid Tumor: Radiomics Compared With Conventional Response Criteria for Predicting Progression During Systemic Therapy-A Multicenter Study by the French Sarcoma Group
Amandine Crombé, Michèle Kind, Isabelle Ray-Coquard, et al.
Annals of Surgical Oncology
|
September 30, 2023
Initial Active Surveillance Strategy for Patients with Peripheral Sporadic Primary Desmoid-Type Fibromatosis: A Multicentric Phase II Observational Trial
Sylvie Bonvalot, Nathalie Cozic, Axel Le Cesne, et al.
Nature Cancer
|
April 9, 2025
Regorafenib plus avelumab in advanced gastroenteropancreatic neuroendocrine neoplasms: a phase 2 trial and correlative analysis
Sophie Cousin, Jean-Philippe Guégan, Lola Jade Palmieri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 30, 2021
Trabectedin plus Durvalumab in Patients with Advanced Pretreated Soft Tissue Sarcoma and Ovarian Carcinoma (TRAMUNE): An Open-Label, Multicenter Phase Ib Study
Maud Toulmonde, Mehdi Brahmi, Antoine Giraud, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 8, 2022
Regorafenib-avelumab combination in patients with biliary tract cancer (REGOMUNE): a single-arm, open-label, phase II trial
Sophie Cousin, Coralie Cantarel, Jean-Philippe Guegan, et al.
Cancers
|
January 10, 2026
The Role of Computed Tomography-Determined Total Tumor Volume at Baseline in Predicting Outcomes of Patients with Locally Advanced Unresectable or Metastatic Pancreatic Ductal Adenocarcinoma
Elissar Moujaes, Jules Dupont, Littisha Lawrance, et al.
Investigative Radiology
|
October 26, 2012
Standardization of dynamic contrast-enhanced ultrasound for the evaluation of antiangiogenic therapies: the French multicenter Support for Innovative and Expensive Techniques Study
Nathalie Lassau, Louis Chapotot, Baya Benatsou, et al.
Page
of 7